Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGF1 | P05230 | 3/20 | 0.37 |
| ▸ | FGF2 | P09038 | 3/20 | 0.37 |
| ▸ | VEGFA | P15692 | 3/20 | 0.37 |
| ▸ | HPSE | Q9Y251 | 3/20 | 0.37 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.36 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.36 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.36 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.36 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.36 |
| ▸ | GJB2 | P29033 | 1/20 | 0.36 |
| ▸ | GJA1 | P17302 | 1/20 | 0.36 |
| ▸ | BCHE | P06276 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | EGFR | P00533 | 1/20 | 0.35 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12406827 | 0.91 | FGF1 (0.36) | FGF1FGF2VEGFAHPSEGJB2 | |
| SCHEMBL13057269 | 0.90 | SSTR1 (0.44) | FGF1FGF2VEGFAHPSESSTR1 | |
| SCHEMBL2172388 | 0.90 | SSTR1 (0.44) | FGF1FGF2VEGFAHPSESSTR1 | |
| SCHEMBL2172392 | 0.90 | SSTR1 (0.44) | FGF1FGF2VEGFAHPSESSTR1 | |
| SCHEMBL13272797 | 0.87 | HPSE (0.41) | FGF1FGF2VEGFAHPSECA1 | |
| SCHEMBL12479738 | 0.87 | HPSE (0.41) | FGF1FGF2VEGFAHPSECA1 | |
| SCHEMBL12406775 | 0.85 | BCHE (0.36) | FGF1FGF2VEGFAHPSESSTR1 | |
| SCHEMBL13057285 | 0.83 | ALDH1A1 (0.38) | BCHEACHEALDH1A1EGFRFKBP1A | |
| SCHEMBL13224946 | 0.83 | TACR1 (0.41) | FGF1FGF2VEGFAHPSESSTR1 | |
| SCHEMBL13057315 | 0.81 | FGF1 (0.42) | FGF1FGF2VEGFAHPSESSTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7973145-B2 | Sulfonated sugar compounds, pharmaceutical compositions which contain the same, and methods of treating tumors with the same | TOYO SUISAN KAISHA, LTD. (JP) | 2011-07-05 | — | — | US | disclosed |
| US-20090209475-A1 | Sulfonated sugar compounds, pharmaceutical compositions which contain the same, and methods of treating tumors with the same | TOYO SUISAN KAISHA, LTD. (JP) | 2009-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090209475-A1 | Sulfonated sugar compounds, pharmaceutical compositions which contain the same, and methods of treating tumors with the same | SLC5A2, SLC5A1, DEGS1 | FGF1 1431/4885FGF2 955/4885VEGFA 4475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.